Gene info
| HGNC approved symbol | MBD2 |
| HGNC ID | HGNC:6917 |
| HGNC approved name | methyl-CpG binding domain protein 2 |
| Entrez gene ID | GeneID:8932 (SSTAR profile) |
| UniProt AC (human) | Q9UBB5 |
| UniProt ID (human) | MBD2_HUMAN |
| Pfam domains | MBD PF01429 (145-216) MBD_C PF14048 (294-387) |
| MGI symbol | Mbd2 |
| MGI ID | MGI:1333813 |
| UniProt AC (mouse) | Q9Z2E1 |
| UniProt ID (mouse) | MBD2_MOUSE |
| HGNC gene family tag | # |
| HGNC gene family description | # |
| Function | Histone modification write cofactor, Histone modification erase cofactor, TF |
| Modification | Histone methylation, Histone acetylation, TF repressor |
| PMID for information on function | PMID:16415179 |
| Protein complex | NuRD, MeCP1 |
| Target molecule | DNA |
| Target entity | mCG, DNA motif |
| HOCOMOCO TFBS model | |
| Product | # |
| PMID for information on target | PMID:16415179 |
| Comment | Wild-type subnuclear distribution of p66alpha and p66beta depends on the presence of MBD2. Both proteins interact with the tails of all octamer histones in vitro, and acetylation of histone tails interferes with p66 binding. |
| Status of entry | # |
Expression statistics
| Expression range: | 7.48 to 267.57 |
| Mean expression: | 55.48 ± 33.25 |
| Median expression: | 47.17 |
| Sample class | Sample | Expression (RLE-normalized CAGE tags per million) | Quantile over all genes |
|---|---|---|---|
| cell_line | acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 211.1 | 0.9 |
| cell_line | splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 177.2 | 0.898 |
| cell_line | lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 173.8 | 0.885 |
| cell_line | B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 151.2 | 0.879 |
| cell_line | plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 146.9 | 0.883 |
| cell_line | mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 146.0 | 0.884 |
| cell_line | B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 142.0 | 0.873 |
| cell_line | Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 134.2 | 0.872 |
| cell_line | lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 132.6 | 0.897 |
| cell_line | xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 128.5 | 0.887 |
| cell_line | B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 126.9 | 0.867 |
| cell_line | keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 115.7 | 0.879 |
| cell_line | epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 115.2 | 0.878 |
| cell_line | hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 107.8 | 0.846 |
| cell_line | NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 103.1 | 0.854 |
| cell_line | cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 92.0 | 0.858 |
| cell_line | Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 92.0 | 0.846 |
| cell_line | Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 90.7 | 0.838 |
| cell_line | Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 87.2 | 0.837 |
| cell_line | large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 85.4 | 0.841 |
| cell_line | Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 85.3 | 0.829 |
| cell_line | adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 85.0 | 0.84 |
| cell_line | Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 84.5 | 0.827 |
| cell_line | b cell line:RPMI1788.CNhs10744.10427-106D4 | 83.8 | 0.837 |
| cell_line | mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 82.9 | 0.847 |
| cell_line | serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 82.8 | 0.872 |
| cell_line | acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 82.2 | 0.805 |
| cell_line | Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 82.1 | 0.828 |
| cell_line | Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 81.8 | 0.831 |
| cell_line | Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 81.6 | 0.831 |
| cell_line | cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 80.8 | 0.817 |
| cell_line | osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 79.4 | 0.808 |
| cell_line | tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 79.2 | 0.818 |
| cell_line | myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 78.2 | 0.852 |
| cell_line | myeloma cell line:PCM6.CNhs11258.10474-106I6 | 78.0 | 0.867 |
| cell_line | Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 76.9 | 0.82 |
| cell_line | spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 75.8 | 0.858 |
| cell_line | breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 75.0 | 0.808 |
| cell_line | oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 74.3 | 0.817 |
| cell_line | anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 74.0 | 0.818 |
| cell_line | cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 72.9 | 0.864 |
| cell_line | endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 71.5 | 0.857 |
| cell_line | sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 71.4 | 0.843 |
| cell_line | diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 71.0 | 0.783 |
| cell_line | glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 70.7 | 0.826 |
| cell_line | cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 69.4 | 0.794 |
| cell_line | bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 68.9 | 0.834 |
| cell_line | mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 68.5 | 0.818 |
| cell_line | mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 67.6 | 0.852 |
| cell_line | mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 67.3 | 0.81 |
| cell_line | breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 66.7 | 0.788 |
| cell_line | Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 65.3 | 0.782 |
| cell_line | myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 64.7 | 0.791 |
| cell_line | hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 64.7 | 0.793 |
| cell_line | papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 64.4 | 0.827 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 63.7 | 0.777 |
| cell_line | malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 63.2 | 0.772 |
| cell_line | thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 62.7 | 0.81 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 62.2 | 0.778 |
| cell_line | epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 61.7 | 0.786 |
| cell_line | squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 60.5 | 0.821 |
| cell_line | acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 60.3 | 0.729 |
| cell_line | serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 60.2 | 0.815 |
| cell_line | lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 58.5 | 0.765 |
| cell_line | chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 57.2 | 0.765 |
| cell_line | serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 56.8 | 0.84 |
| cell_line | oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 56.0 | 0.8 |
| cell_line | medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 55.4 | 0.77 |
| cell_line | prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 54.2 | 0.777 |
| cell_line | somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 53.7 | 0.787 |
| cell_line | chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 53.7 | 0.76 |
| cell_line | epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 53.6 | 0.746 |
| cell_line | acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 53.3 | 0.764 |
| cell_line | mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 52.1 | 0.771 |
| cell_line | epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 51.3 | 0.753 |
| cell_line | bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 51.3 | 0.758 |
| cell_line | gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 50.9 | 0.799 |
| cell_line | neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 50.6 | 0.808 |
| cell_line | mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 49.2 | 0.747 |
| cell_line | schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 48.9 | 0.783 |
| cell_line | small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 48.8 | 0.713 |
| cell_line | acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 48.7 | 0.712 |
| cell_line | mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 48.7 | 0.777 |
| cell_line | leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 48.4 | 0.735 |
| cell_line | small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 48.3 | 0.705 |
| cell_line | fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 48.2 | 0.775 |
| cell_line | acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 47.9 | 0.684 |
| cell_line | lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 47.7 | 0.791 |
| cell_line | acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 47.6 | 0.678 |
| cell_line | mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 46.5 | 0.782 |
| cell_line | anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 46.5 | 0.789 |
| cell_line | acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 45.9 | 0.654 |
| cell_line | Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 45.5 | 0.648 |
| cell_line | mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 45.5 | 0.769 |
| cell_line | hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 45.4 | 0.801 |
| cell_line | osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 45.4 | 0.783 |
| cell_line | pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 45.3 | 0.745 |
| cell_line | Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 45.2 | 0.726 |
| cell_line | pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 45.1 | 0.757 |
| cell_line | biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 45.0 | 0.718 |
| cell_line | mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 44.8 | 0.726 |
| cell_line | acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 44.7 | 0.707 |
| cell_line | schwannoma cell line:HS-PSS, tech_rep1.CNhs11183.10442-106F1 | 44.6 | 0.768 |
| cell_line | bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 44.0 | 0.73 |
| cell_line | acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 43.9 | 0.713 |
| cell_line | small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 43.7 | 0.709 |
| cell_line | epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 43.7 | 0.705 |
| cell_line | neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 43.6 | 0.672 |
| cell_line | small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 43.6 | 0.65 |
| cell_line | adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 43.6 | 0.708 |
| cell_line | acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 43.5 | 0.703 |
| cell_line | astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 43.5 | 0.735 |
| cell_line | cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 43.3 | 0.644 |
| cell_line | squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 43.1 | 0.758 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 42.7 | 0.699 |
| cell_line | liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 42.4 | 0.735 |
| cell_line | granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 42.1 | 0.736 |
| cell_line | adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 42.1 | 0.731 |
| cell_line | prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 42.0 | 0.738 |
| cell_line | maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 41.9 | 0.677 |
| cell_line | mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 41.9 | 0.735 |
| cell_line | melanoma cell line:G-361.CNhs11254.10465-106H6 | 41.7 | 0.755 |
| cell_line | acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 41.0 | 0.701 |
| cell_line | epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 40.8 | 0.728 |
| cell_line | basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 40.7 | 0.787 |
| cell_line | lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 40.7 | 0.689 |
| cell_line | mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 40.6 | 0.736 |
| cell_line | choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 40.5 | 0.712 |
| cell_line | Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 40.3 | 0.786 |
| cell_line | leiomyoma cell line:15425.CNhs11724.10571-108B4 | 39.8 | 0.799 |
| cell_line | oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 39.4 | 0.729 |
| cell_line | embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 39.4 | 0.677 |
| cell_line | ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 39.3 | 0.694 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 39.3 | 0.677 |
| cell_line | acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 39.3 | 0.614 |
| cell_line | mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 38.0 | 0.723 |
| cell_line | medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 37.9 | 0.609 |
| cell_line | endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 37.7 | 0.722 |
| cell_line | synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 37.2 | 0.634 |
| cell_line | transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 37.2 | 0.661 |
| cell_line | choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 37.1 | 0.665 |
| cell_line | acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 37.1 | 0.668 |
| cell_line | argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 37.0 | 0.684 |
| cell_line | hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 36.9 | 0.65 |
| cell_line | glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 36.8 | 0.685 |
| cell_line | bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 36.1 | 0.692 |
| cell_line | giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 35.9 | 0.691 |
| cell_line | hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 35.9 | 0.649 |
| cell_line | rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 35.8 | 0.644 |
| cell_line | melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 35.8 | 0.7 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 35.2 | 0.638 |
| cell_line | normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 34.9 | 0.742 |
| cell_line | chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 34.8 | 0.657 |
| cell_line | acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 34.5 | 0.621 |
| cell_line | mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 34.4 | 0.692 |
| cell_line | acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 34.4 | 0.662 |
| cell_line | rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 34.2 | 0.628 |
| cell_line | clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 34.2 | 0.703 |
| cell_line | transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 34.0 | 0.637 |
| cell_line | signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 34.0 | 0.673 |
| cell_line | large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 33.8 | 0.662 |
| cell_line | hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 33.6 | 0.625 |
| cell_line | meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 33.4 | 0.719 |
| cell_line | leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 33.1 | 0.778 |
| cell_line | leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 33.1 | 0.639 |
| cell_line | renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 33.0 | 0.668 |
| cell_line | mesothelioma cell line:No36.CNhs13074.10857-111G2 | 32.8 | 0.685 |
| cell_line | fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 32.6 | 0.663 |
| cell_line | bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 32.5 | 0.636 |
| cell_line | large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 32.5 | 0.712 |
| cell_line | teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 32.4 | 0.631 |
| cell_line | leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 32.0 | 0.776 |
| cell_line | mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 31.8 | 0.696 |
| cell_line | serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 31.6 | 0.648 |
| cell_line | bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 31.3 | 0.677 |
| cell_line | gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 30.6 | 0.669 |
| cell_line | extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 30.5 | 0.605 |
| cell_line | non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 30.4 | 0.613 |
| cell_line | clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 30.2 | 0.653 |
| cell_line | acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 29.8 | 0.565 |
| cell_line | hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 29.7 | 0.64 |
| cell_line | pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 29.2 | 0.638 |
| cell_line | chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 29.2 | 0.53 |
| cell_line | glioblastoma cell line:A172, tech_rep1.CNhs11185.10444-106F3 | 28.8 | 0.605 |
| cell_line | tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 28.5 | 0.679 |
| cell_line | acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 28.1 | 0.582 |
| cell_line | gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 27.8 | 0.564 |
| cell_line | merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 27.6 | 0.51 |
| cell_line | mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 27.4 | 0.646 |
| cell_line | myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 27.3 | 0.556 |
| cell_line | embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 27.3 | 0.588 |
| cell_line | normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 27.2 | 0.661 |
| cell_line | teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 27.1 | 0.571 |
| cell_line | papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 27.1 | 0.551 |
| cell_line | mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 26.9 | 0.625 |
| cell_line | acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 26.6 | 0.548 |
| cell_line | glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 25.8 | 0.574 |
| cell_line | ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 25.2 | 0.593 |
| cell_line | non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 25.2 | 0.421 |
| cell_line | acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 25.1 | 0.542 |
| cell_line | gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 25.1 | 0.581 |
| cell_line | choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 25.0 | 0.552 |
| cell_line | gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 24.5 | 0.499 |
| cell_line | gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 24.5 | 0.546 |
| cell_line | chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 23.9 | 0.521 |
| cell_line | neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 23.8 | 0.476 |
| cell_line | Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 23.7 | 0.553 |
| cell_line | cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 23.6 | 0.571 |
| cell_line | pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 23.5 | 0.568 |
| cell_line | embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 23.5 | 0.439 |
| cell_line | acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 23.4 | 0.554 |
| cell_line | liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 23.3 | 0.603 |
| cell_line | carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 23.3 | 0.548 |
| cell_line | renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 23.1 | 0.591 |
| cell_line | peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 22.9 | 0.504 |
| cell_line | giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 22.6 | 0.622 |
| cell_line | rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 22.6 | 0.435 |
| cell_line | chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 22.5 | 0.494 |
| cell_line | anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 22.4 | 0.425 |
| cell_line | testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 22.3 | 0.527 |
| cell_line | colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 22.3 | 0.45 |
| cell_line | glioma cell line:GI-1.CNhs10731.10413-106B8 | 22.2 | 0.518 |
| cell_line | endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 22.2 | 0.552 |
| cell_line | mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 22.2 | 0.596 |
| cell_line | embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 21.7 | 0.531 |
| cell_line | teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 21.5 | 0.492 |
| cell_line | alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 21.3 | 0.528 |
| cell_line | chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 21.2 | 0.483 |
| cell_line | signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 21.1 | 0.518 |
| cell_line | carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 20.7 | 0.447 |
| cell_line | acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 20.3 | 0.49 |
| cell_line | neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 20.0 | 0.407 |
| cell_line | testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 19.8 | 0.464 |
| cell_line | embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 19.6 | 0.484 |
| cell_line | mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 19.3 | 0.533 |
| cell_line | hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 18.6 | 0.408 |
| cell_line | oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 18.3 | 0.481 |
| cell_line | testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 18.2 | 0.429 |
| cell_line | small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 16.0 | 0.429 |
| cell_line | neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 16.0 | 0.347 |
| cell_line | chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 15.9 | 0.427 |
| cell_line | squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 15.9 | 0.433 |
| cell_line | neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 15.6 | 0.364 |
| cell_line | merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 15.4 | 0.338 |
| cell_line | embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 14.9 | 0.46 |
| cell_line | small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 14.7 | 0.398 |
| cell_line | osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 13.7 | 0.366 |
| cell_line | neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 13.4 | 0.375 |
| cell_line | carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 13.1 | 0.361 |
| cell_line | testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 13.0 | 0.37 |
| cell_line | neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 12.9 | 0.349 |
| cell_line | retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 10.0 | 0.248 |
| cell_line | colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 9.6 | 0.303 |
| cell_line | neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 7.5 | 0.211 |
| cell_line | small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 7.5 | 0.23 |
| fractionation | Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 71.0 | 0.837 |
| fractionation | Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 51.1 | 0.835 |
| fractionation | Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 43.7 | 0.709 |
| fractionation | Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 43.5 | 0.745 |
| fractionation | Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 41.1 | 0.684 |
| fractionation | Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 39.8 | 0.72 |
| fractionation | Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 35.3 | 0.663 |
| fractionation | Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 33.3 | 0.666 |
| fractionation | Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 33.1 | 0.709 |
| fractionation | Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 32.7 | 0.692 |
| fractionation | Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 30.4 | 0.588 |
| fractionation | Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 27.6 | 0.617 |
| primary_cell | Eosinophils, donor3.CNhs12549.12246-129H5 | 267.6 | 0.887 |
| primary_cell | CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 229.6 | 0.93 |
| primary_cell | CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 222.8 | 0.933 |
| primary_cell | mature adipocyte, donor1.CNhs12558.12231-129F8 | 208.9 | 0.955 |
| primary_cell | CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 186.4 | 0.919 |
| primary_cell | mature adipocyte, donor2.CNhs12559.12232-129F9 | 185.3 | 0.953 |
| primary_cell | Eosinophils, donor2.CNhs12548.12245-129H4 | 183.2 | 0.86 |
| primary_cell | CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 174.5 | 0.91 |
| primary_cell | Neutrophils, donor2.CNhs11959.11314-117C9 | 164.5 | 0.868 |
| primary_cell | Neutrophils, donor3.CNhs11905.11390-118C4 | 161.6 | 0.838 |
| primary_cell | CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 160.5 | 0.918 |
| primary_cell | Neutrophils, donor1.CNhs10862.11233-116C9 | 155.8 | 0.854 |
| primary_cell | CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 155.6 | 0.9 |
| primary_cell | Basophils, donor3.CNhs12575.12243-129H2 | 150.9 | 0.907 |
| primary_cell | CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 150.2 | 0.902 |
| primary_cell | mature adipocyte, donor3.CNhs12560.12233-129G1 | 147.7 | 0.938 |
| primary_cell | nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 147.4 | 0.913 |
| primary_cell | CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 146.9 | 0.932 |
| primary_cell | CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 146.3 | 0.913 |
| primary_cell | CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 144.5 | 0.91 |
| primary_cell | Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 142.9 | 0.919 |
| primary_cell | chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 141.3 | 0.914 |
| primary_cell | amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 137.3 | 0.914 |
| primary_cell | Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 131.3 | 0.897 |
| primary_cell | CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 131.2 | 0.916 |
| primary_cell | salivary acinar cells, donor3.CNhs12812.11773-123I9 | 130.6 | 0.901 |
| primary_cell | CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 130.0 | 0.906 |
| primary_cell | CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 129.6 | 0.898 |
| primary_cell | CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 129.1 | 0.901 |
| primary_cell | CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 126.4 | 0.906 |
| primary_cell | CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 125.3 | 0.884 |
| primary_cell | CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 124.4 | 0.886 |
| primary_cell | granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 123.9 | 0.839 |
| primary_cell | Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 123.0 | 0.914 |
| primary_cell | CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 122.8 | 0.901 |
| primary_cell | Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 122.6 | 0.884 |
| primary_cell | CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 122.0 | 0.9 |
| primary_cell | CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 121.5 | 0.88 |
| primary_cell | Basophils, donor1.CNhs12546.12241-129G9 | 121.2 | 0.879 |
| primary_cell | Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 118.9 | 0.884 |
| primary_cell | CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 118.4 | 0.898 |
| primary_cell | CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 118.3 | 0.866 |
| primary_cell | CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 112.3 | 0.904 |
| primary_cell | CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 111.7 | 0.906 |
| primary_cell | Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 111.4 | 0.904 |
| primary_cell | chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 111.3 | 0.892 |
| primary_cell | Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 109.7 | 0.879 |
| primary_cell | CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 108.9 | 0.904 |
| primary_cell | amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 108.6 | 0.895 |
| primary_cell | mature adipocyte, donor4.CNhs12562.12234-129G2 | 108.5 | 0.904 |
| primary_cell | CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 107.7 | 0.891 |
| primary_cell | CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 105.5 | 0.855 |
| primary_cell | Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 102.7 | 0.9 |
| primary_cell | CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 102.4 | 0.883 |
| primary_cell | CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 102.4 | 0.88 |
| primary_cell | Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 102.4 | 0.867 |
| primary_cell | CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 102.1 | 0.873 |
| primary_cell | CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 101.6 | 0.862 |
| primary_cell | Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 100.5 | 0.872 |
| primary_cell | CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 100.0 | 0.844 |
| primary_cell | CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 99.9 | 0.87 |
| primary_cell | CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 99.4 | 0.863 |
| primary_cell | CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 99.3 | 0.87 |
| primary_cell | Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 98.9 | 0.887 |
| primary_cell | Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 98.9 | 0.9 |
| primary_cell | Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 98.0 | 0.88 |
| primary_cell | amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 96.5 | 0.867 |
| primary_cell | CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 96.1 | 0.866 |
| primary_cell | Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 96.1 | 0.908 |
| primary_cell | CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 95.6 | 0.886 |
| primary_cell | Basophils, donor2.CNhs12563.12242-129H1 | 91.7 | 0.849 |
| primary_cell | CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 91.7 | 0.862 |
| primary_cell | Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 91.5 | 0.851 |
| primary_cell | CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 89.9 | 0.851 |
| primary_cell | CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 89.8 | 0.864 |
| primary_cell | CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 89.7 | 0.846 |
| primary_cell | CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 88.1 | 0.854 |
| primary_cell | CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 87.3 | 0.824 |
| primary_cell | Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 87.3 | 0.852 |
| primary_cell | Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 86.5 | 0.861 |
| primary_cell | CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 85.3 | 0.854 |
| primary_cell | tenocyte, donor2.CNhs12640.11765-123I1 | 85.0 | 0.886 |
| primary_cell | CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 84.7 | 0.856 |
| primary_cell | Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 84.2 | 0.86 |
| primary_cell | CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 84.1 | 0.811 |
| primary_cell | Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 84.1 | 0.828 |
| primary_cell | Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 83.3 | 0.892 |
| primary_cell | Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 82.5 | 0.883 |
| primary_cell | Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 82.2 | 0.879 |
| primary_cell | Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 82.1 | 0.889 |
| primary_cell | Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 81.9 | 0.835 |
| primary_cell | Mast cell, donor3.CNhs12593.11566-120D9 | 81.3 | 0.817 |
| primary_cell | Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 81.2 | 0.852 |
| primary_cell | Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 81.0 | 0.881 |
| primary_cell | Sebocyte, donor1.CNhs10847.11220-116B5 | 81.0 | 0.864 |
| primary_cell | Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 80.9 | 0.827 |
| primary_cell | Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 80.5 | 0.88 |
| primary_cell | Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 80.5 | 0.847 |
| primary_cell | Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 80.5 | 0.844 |
| primary_cell | CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 80.4 | 0.804 |
| primary_cell | Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 80.1 | 0.851 |
| primary_cell | Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 79.0 | 0.862 |
| primary_cell | Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 78.9 | 0.864 |
| primary_cell | Sertoli Cells, donor1.CNhs10851.11255-116F4 | 78.7 | 0.874 |
| primary_cell | Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 78.0 | 0.839 |
| primary_cell | CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 77.5 | 0.776 |
| primary_cell | Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 77.2 | 0.832 |
| primary_cell | tenocyte, donor1.CNhs12639.11763-123H8 | 77.0 | 0.863 |
| primary_cell | Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 76.8 | 0.846 |
| primary_cell | Dendritic Cells - monocyte immature derived, donor1, rep2.CNhs11062.11227-116C3 | 76.6 | 0.89 |
| primary_cell | migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 76.4 | 0.844 |
| primary_cell | Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 75.4 | 0.827 |
| primary_cell | Mast cell, donor4.CNhs12592.11567-120E1 | 75.2 | 0.81 |
| primary_cell | Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 75.1 | 0.847 |
| primary_cell | CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 74.6 | 0.786 |
| primary_cell | Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 73.9 | 0.87 |
| primary_cell | Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 73.5 | 0.841 |
| primary_cell | Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 73.4 | 0.883 |
| primary_cell | tenocyte, donor3.CNhs12641.11768-123I4 | 73.1 | 0.87 |
| primary_cell | Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 72.9 | 0.841 |
| primary_cell | Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 72.9 | 0.787 |
| primary_cell | Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 72.9 | 0.88 |
| primary_cell | CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 72.6 | 0.881 |
| primary_cell | Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 72.4 | 0.849 |
| primary_cell | Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 71.9 | 0.78 |
| primary_cell | Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 71.8 | 0.879 |
| primary_cell | Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 71.8 | 0.877 |
| primary_cell | CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 71.1 | 0.777 |
| primary_cell | Sebocyte, donor2.CNhs11951.11301-117B5 | 70.9 | 0.849 |
| primary_cell | Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 70.7 | 0.847 |
| primary_cell | Mast cell, donor2.CNhs12594.11565-120D8 | 70.7 | 0.798 |
| primary_cell | CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 70.5 | 0.824 |
| primary_cell | CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 70.3 | 0.828 |
| primary_cell | Synoviocyte, donor3.CNhs12050.11440-118H9 | 70.1 | 0.879 |
| primary_cell | Synoviocyte, donor2.CNhs11992.11368-117I9 | 69.5 | 0.877 |
| primary_cell | Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 69.5 | 0.879 |
| primary_cell | Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 69.4 | 0.857 |
| primary_cell | CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 69.3 | 0.835 |
| primary_cell | Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 69.0 | 0.846 |
| primary_cell | CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 68.7 | 0.868 |
| primary_cell | Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 68.5 | 0.828 |
| primary_cell | Urothelial cells, donor0.CNhs10843.11216-116B1 | 68.2 | 0.872 |
| primary_cell | Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 68.1 | 0.76 |
| primary_cell | Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 68.0 | 0.828 |
| primary_cell | Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 67.0 | 0.844 |
| primary_cell | CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 66.9 | 0.77 |
| primary_cell | migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 66.2 | 0.829 |
| primary_cell | Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 66.2 | 0.837 |
| primary_cell | CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 66.1 | 0.809 |
| primary_cell | Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 66.0 | 0.827 |
| primary_cell | Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 65.6 | 0.838 |
| primary_cell | CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 65.5 | 0.809 |
| primary_cell | Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 65.3 | 0.827 |
| primary_cell | CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 65.2 | 0.758 |
| primary_cell | Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 65.1 | 0.838 |
| primary_cell | Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 65.0 | 0.843 |
| primary_cell | Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 64.5 | 0.835 |
| primary_cell | Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 64.5 | 0.867 |
| primary_cell | salivary acinar cells, donor1.CNhs12810.11771-123I7 | 64.4 | 0.838 |
| primary_cell | Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 64.4 | 0.828 |
| primary_cell | chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 64.3 | 0.843 |
| primary_cell | Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 64.3 | 0.847 |
| primary_cell | CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 63.9 | 0.806 |
| primary_cell | Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 63.7 | 0.856 |
| primary_cell | CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 63.2 | 0.81 |
| primary_cell | Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 63.0 | 0.833 |
| primary_cell | Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 62.9 | 0.864 |
| primary_cell | mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 62.4 | 0.843 |
| primary_cell | mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 62.4 | 0.852 |
| primary_cell | CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 62.0 | 0.751 |
| primary_cell | Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 62.0 | 0.832 |
| primary_cell | CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 61.8 | 0.844 |
| primary_cell | Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 61.8 | 0.822 |
| primary_cell | CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 61.6 | 0.808 |
| primary_cell | Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 61.6 | 0.854 |
| primary_cell | Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 61.4 | 0.829 |
| primary_cell | mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 61.4 | 0.855 |
| primary_cell | Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 61.1 | 0.858 |
| primary_cell | CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 60.8 | 0.811 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 60.7 | 0.795 |
| primary_cell | mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 60.6 | 0.815 |
| primary_cell | mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 60.6 | 0.858 |
| primary_cell | Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 60.6 | 0.845 |
| primary_cell | Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 60.5 | 0.869 |
| primary_cell | Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 60.4 | 0.82 |
| primary_cell | Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 60.0 | 0.827 |
| primary_cell | Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 60.0 | 0.828 |
| primary_cell | Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 59.9 | 0.858 |
| primary_cell | mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 59.9 | 0.826 |
| primary_cell | Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 59.8 | 0.84 |
| primary_cell | Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 59.8 | 0.805 |
| primary_cell | Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 59.7 | 0.8 |
| primary_cell | Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 59.6 | 0.847 |
| primary_cell | Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 59.6 | 0.816 |
| primary_cell | Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 59.5 | 0.835 |
| primary_cell | Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 59.2 | 0.787 |
| primary_cell | Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 59.0 | 0.852 |
| primary_cell | Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 58.9 | 0.843 |
| primary_cell | Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 58.8 | 0.821 |
| primary_cell | Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 58.7 | 0.816 |
| primary_cell | CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 58.7 | 0.742 |
| primary_cell | Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 58.7 | 0.829 |
| primary_cell | Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 58.6 | 0.794 |
| primary_cell | Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 58.4 | 0.799 |
| primary_cell | Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 58.2 | 0.82 |
| primary_cell | Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 58.1 | 0.823 |
| primary_cell | migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 57.7 | 0.792 |
| primary_cell | Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 57.6 | 0.814 |
| primary_cell | Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 57.5 | 0.82 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 57.1 | 0.766 |
| primary_cell | Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 56.8 | 0.763 |
| primary_cell | CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 56.6 | 0.795 |
| primary_cell | Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 56.5 | 0.82 |
| primary_cell | Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 56.5 | 0.818 |
| primary_cell | CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 56.4 | 0.768 |
| primary_cell | Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 56.2 | 0.822 |
| primary_cell | Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 56.1 | 0.82 |
| primary_cell | mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 55.7 | 0.815 |
| primary_cell | Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 55.5 | 0.795 |
| primary_cell | mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 55.5 | 0.817 |
| primary_cell | Urothelial Cells, donor3.CNhs12122.11681-122H7 | 55.4 | 0.821 |
| primary_cell | Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 55.0 | 0.821 |
| primary_cell | Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 54.9 | 0.801 |
| primary_cell | mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 54.8 | 0.847 |
| primary_cell | Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 54.7 | 0.809 |
| primary_cell | Myoblast, donor3.CNhs11908.11398-118D3 | 54.6 | 0.827 |
| primary_cell | mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 54.5 | 0.829 |
| primary_cell | Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 54.5 | 0.839 |
| primary_cell | Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 54.4 | 0.822 |
| primary_cell | Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 54.3 | 0.831 |
| primary_cell | Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 54.3 | 0.847 |
| primary_cell | Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 54.2 | 0.815 |
| primary_cell | Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 54.1 | 0.749 |
| primary_cell | Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 54.1 | 0.804 |
| primary_cell | Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 54.0 | 0.845 |
| primary_cell | Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 53.9 | 0.839 |
| primary_cell | Urothelial Cells, donor1.CNhs11334.11520-119H8 | 53.8 | 0.817 |
| primary_cell | Keratocytes, donor1.CNhs11337.11527-119I6 | 53.8 | 0.788 |
| primary_cell | Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 53.3 | 0.832 |
| primary_cell | mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 53.1 | 0.821 |
| primary_cell | Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 53.1 | 0.803 |
| primary_cell | Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 53.0 | 0.847 |
| primary_cell | Myoblast, donor2.CNhs11965.11322-117D8 | 52.6 | 0.814 |
| primary_cell | Mast cell, donor1.CNhs12566.11563-120D6 | 52.5 | 0.758 |
| primary_cell | Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 52.4 | 0.791 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 52.4 | 0.755 |
| primary_cell | Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 52.4 | 0.851 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 52.4 | 0.766 |
| primary_cell | Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 52.4 | 0.789 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 52.3 | 0.762 |
| primary_cell | Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 52.1 | 0.832 |
| primary_cell | Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 52.0 | 0.841 |
| primary_cell | Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 51.7 | 0.829 |
| primary_cell | Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 51.5 | 0.787 |
| primary_cell | CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 51.3 | 0.755 |
| primary_cell | Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 51.2 | 0.78 |
| primary_cell | Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 51.0 | 0.817 |
| primary_cell | Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 51.0 | 0.854 |
| primary_cell | Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 50.9 | 0.789 |
| primary_cell | mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 50.7 | 0.82 |
| primary_cell | salivary acinar cells, donor2.CNhs12811.11772-123I8 | 50.7 | 0.803 |
| primary_cell | Hepatocyte, donor1.CNhs12340.11523-119I2 | 50.7 | 0.82 |
| primary_cell | Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 50.7 | 0.835 |
| primary_cell | Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 50.6 | 0.771 |
| primary_cell | Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 50.5 | 0.811 |
| primary_cell | mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 50.3 | 0.805 |
| primary_cell | Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 50.3 | 0.803 |
| primary_cell | Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 50.1 | 0.798 |
| primary_cell | CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 50.0 | 0.741 |
| primary_cell | nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 49.9 | 0.841 |
| primary_cell | Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 49.9 | 0.788 |
| primary_cell | Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 49.7 | 0.81 |
| primary_cell | Melanocyte - light, donor3.CNhs12033.11423-118G1 | 49.6 | 0.792 |
| primary_cell | Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 49.5 | 0.74 |
| primary_cell | CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 49.5 | 0.726 |
| primary_cell | Hepatocyte, donor2.CNhs12349.11603-120I1 | 49.1 | 0.816 |
| primary_cell | Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 49.1 | 0.831 |
| primary_cell | CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 49.0 | 0.724 |
| primary_cell | Melanocyte - light, donor1.CNhs11303.11274-116H5 | 48.9 | 0.778 |
| primary_cell | Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 48.9 | 0.839 |
| primary_cell | Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 48.8 | 0.785 |
| primary_cell | Osteoblast, donor3.CNhs12036.11426-118G4 | 48.7 | 0.785 |
| primary_cell | Osteoblast, donor2.CNhs11385.11354-117H4 | 48.5 | 0.785 |
| primary_cell | Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 48.4 | 0.805 |
| primary_cell | Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 48.2 | 0.817 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 48.1 | 0.742 |
| primary_cell | mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 48.1 | 0.829 |
| primary_cell | Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 48.0 | 0.801 |
| primary_cell | CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 47.9 | 0.719 |
| primary_cell | Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 47.9 | 0.768 |
| primary_cell | Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 47.5 | 0.818 |
| primary_cell | Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 47.2 | 0.801 |
| primary_cell | Myoblast, donor1.CNhs10870.11241-116D8 | 47.2 | 0.814 |
| primary_cell | Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 47.2 | 0.746 |
| primary_cell | Urothelial Cells, donor2.CNhs12091.11600-120H7 | 47.2 | 0.805 |
| primary_cell | mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 47.2 | 0.822 |
| primary_cell | Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 47.1 | 0.786 |
| primary_cell | CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 46.8 | 0.705 |
| primary_cell | mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 46.7 | 0.809 |
| primary_cell | Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 46.7 | 0.772 |
| primary_cell | Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 46.5 | 0.781 |
| primary_cell | Meningeal Cells, donor3.CNhs12731.11654-122E7 | 46.4 | 0.751 |
| primary_cell | Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 46.3 | 0.738 |
| primary_cell | Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 46.1 | 0.82 |
| primary_cell | CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 46.0 | 0.679 |
| primary_cell | Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 46.0 | 0.774 |
| primary_cell | Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 45.8 | 0.799 |
| primary_cell | Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 45.5 | 0.811 |
| primary_cell | Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 45.5 | 0.766 |
| primary_cell | Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 45.5 | 0.812 |
| primary_cell | Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 45.4 | 0.811 |
| primary_cell | Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 45.2 | 0.801 |
| primary_cell | Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 44.9 | 0.789 |
| primary_cell | Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 44.8 | 0.766 |
| primary_cell | Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 44.8 | 0.763 |
| primary_cell | Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 44.7 | 0.775 |
| primary_cell | Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 44.6 | 0.815 |
| primary_cell | Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 44.5 | 0.783 |
| primary_cell | Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 44.5 | 0.792 |
| primary_cell | Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 44.3 | 0.731 |
| primary_cell | Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 44.1 | 0.702 |
| primary_cell | immature langerhans cells, donor1.CNhs13537.11904-125F5 | 44.1 | 0.696 |
| primary_cell | Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 44.0 | 0.783 |
| primary_cell | mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 43.8 | 0.793 |
| primary_cell | Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 43.6 | 0.758 |
| primary_cell | Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 43.5 | 0.751 |
| primary_cell | Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 43.3 | 0.76 |
| primary_cell | Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 43.3 | 0.827 |
| primary_cell | Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 43.3 | 0.766 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 43.1 | 0.709 |
| primary_cell | CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 42.8 | 0.682 |
| primary_cell | Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 42.6 | 0.785 |
| primary_cell | Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 42.3 | 0.746 |
| primary_cell | mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 42.3 | 0.809 |
| primary_cell | Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 42.2 | 0.801 |
| primary_cell | Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 42.0 | 0.76 |
| primary_cell | CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 42.0 | 0.695 |
| primary_cell | Hepatocyte, donor3.CNhs12626.11684-122I1 | 41.9 | 0.764 |
| primary_cell | Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 41.8 | 0.748 |
| primary_cell | Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 41.8 | 0.742 |
| primary_cell | Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 41.7 | 0.776 |
| primary_cell | Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 41.6 | 0.719 |
| primary_cell | Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 41.5 | 0.708 |
| primary_cell | Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 41.4 | 0.731 |
| primary_cell | mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 41.0 | 0.783 |
| primary_cell | Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 41.0 | 0.768 |
| primary_cell | Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 41.0 | 0.788 |
| primary_cell | Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 41.0 | 0.758 |
| primary_cell | Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 40.9 | 0.789 |
| primary_cell | CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 40.9 | 0.709 |
| primary_cell | Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 40.8 | 0.765 |
| primary_cell | Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 40.8 | 0.809 |
| primary_cell | mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 40.7 | 0.808 |
| primary_cell | CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 40.7 | 0.674 |
| primary_cell | Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 40.3 | 0.757 |
| primary_cell | Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 40.2 | 0.745 |
| primary_cell | Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 40.1 | 0.801 |
| primary_cell | Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 40.0 | 0.782 |
| primary_cell | Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 40.0 | 0.758 |
| primary_cell | mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 39.8 | 0.765 |
| primary_cell | Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 39.5 | 0.758 |
| primary_cell | Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 39.4 | 0.777 |
| primary_cell | Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 39.3 | 0.747 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 39.3 | 0.645 |
| primary_cell | Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 39.2 | 0.777 |
| primary_cell | Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 38.9 | 0.755 |
| primary_cell | Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 38.8 | 0.751 |
| primary_cell | Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 38.6 | 0.667 |
| primary_cell | Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 38.6 | 0.755 |
| primary_cell | Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 38.5 | 0.726 |
| primary_cell | Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 38.3 | 0.725 |
| primary_cell | Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 38.2 | 0.753 |
| primary_cell | Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 38.2 | 0.726 |
| primary_cell | Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 38.1 | 0.786 |
| primary_cell | Meningeal Cells, donor2.CNhs12080.11573-120E7 | 37.9 | 0.728 |
| primary_cell | CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 37.9 | 0.677 |
| primary_cell | Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 37.8 | 0.72 |
| primary_cell | Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 37.6 | 0.751 |
| primary_cell | CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 37.6 | 0.66 |
| primary_cell | Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 37.4 | 0.735 |
| primary_cell | Meningeal Cells, donor1.CNhs11320.11493-119E8 | 37.2 | 0.701 |
| primary_cell | Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 37.2 | 0.676 |
| primary_cell | Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 37.1 | 0.791 |
| primary_cell | Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 37.0 | 0.718 |
| primary_cell | Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 36.9 | 0.743 |
| primary_cell | Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 36.9 | 0.728 |
| primary_cell | Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 36.8 | 0.757 |
| primary_cell | Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 36.8 | 0.791 |
| primary_cell | Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 36.7 | 0.751 |
| primary_cell | mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 36.7 | 0.759 |
| primary_cell | CD34 cells differentiated to erythrocyte lineage, biol_ rep2.CNhs13553.11932-125I6 | 36.6 | 0.621 |
| primary_cell | Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 36.5 | 0.769 |
| primary_cell | Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 36.4 | 0.759 |
| primary_cell | Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 36.2 | 0.741 |
| primary_cell | Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 36.2 | 0.746 |
| primary_cell | Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 36.1 | 0.746 |
| primary_cell | Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 36.0 | 0.688 |
| primary_cell | Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 36.0 | 0.732 |
| primary_cell | CD34 cells differentiated to erythrocyte lineage, biol_ rep1.CNhs13552.11931-125I5 | 35.5 | 0.588 |
| primary_cell | Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 35.3 | 0.665 |
| primary_cell | Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 35.1 | 0.73 |
| primary_cell | CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 35.1 | 0.631 |
| primary_cell | Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 35.0 | 0.741 |
| primary_cell | Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 34.6 | 0.713 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 34.5 | 0.596 |
| primary_cell | Keratocytes, donor2.CNhs12095.11607-120I5 | 34.3 | 0.73 |
| primary_cell | Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 34.1 | 0.749 |
| primary_cell | Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 33.7 | 0.692 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 33.5 | 0.594 |
| primary_cell | Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 33.4 | 0.699 |
| primary_cell | Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 33.3 | 0.69 |
| primary_cell | Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 33.2 | 0.711 |
| primary_cell | Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 33.2 | 0.696 |
| primary_cell | Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 33.0 | 0.731 |
| primary_cell | Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 32.8 | 0.746 |
| primary_cell | Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 32.3 | 0.702 |
| primary_cell | Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 32.3 | 0.74 |
| primary_cell | Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 31.9 | 0.692 |
| primary_cell | Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 31.8 | 0.663 |
| primary_cell | Pericytes, donor2.CNhs12079.11571-120E5 | 31.2 | 0.709 |
| primary_cell | mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 30.8 | 0.726 |
| primary_cell | Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 30.4 | 0.713 |
| primary_cell | Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 29.5 | 0.596 |
| primary_cell | Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 29.4 | 0.682 |
| primary_cell | Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 29.2 | 0.665 |
| primary_cell | Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 29.1 | 0.674 |
| primary_cell | Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 29.0 | 0.683 |
| primary_cell | Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 28.7 | 0.685 |
| primary_cell | Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 28.6 | 0.594 |
| primary_cell | Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 28.6 | 0.646 |
| primary_cell | Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 28.2 | 0.663 |
| primary_cell | Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 28.2 | 0.695 |
| primary_cell | Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 27.8 | 0.642 |
| primary_cell | Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 27.6 | 0.621 |
| primary_cell | Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 27.3 | 0.643 |
| primary_cell | Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 27.2 | 0.662 |
| primary_cell | Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 27.1 | 0.696 |
| primary_cell | Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 26.9 | 0.724 |
| primary_cell | CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 26.7 | 0.529 |
| primary_cell | Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 26.4 | 0.705 |
| primary_cell | immature langerhans cells, donor2.CNhs13480.11905-125F6 | 26.3 | 0.548 |
| primary_cell | Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 26.2 | 0.626 |
| primary_cell | Melanocyte - light, donor2.CNhs11383.11351-117H1 | 25.8 | 0.63 |
| primary_cell | Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 25.6 | 0.513 |
| primary_cell | Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 25.6 | 0.64 |
| primary_cell | Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 24.9 | 0.645 |
| primary_cell | Neural stem cells, donor2.CNhs11384.11352-117H2 | 24.7 | 0.478 |
| primary_cell | Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 24.6 | 0.643 |
| primary_cell | Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 24.3 | 0.689 |
| primary_cell | Pericytes, donor1.CNhs11317.11491-119E6 | 24.1 | 0.651 |
| primary_cell | Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 23.1 | 0.632 |
| primary_cell | Neural stem cells, donor1.CNhs11063.11275-116H6 | 22.9 | 0.513 |
| primary_cell | Neurons, donor1.CNhs12338.11494-119E9 | 20.1 | 0.473 |
| primary_cell | Neurons, donor3.CNhs13815.11655-122E8 | 19.1 | 0.479 |
| primary_cell | Neurons, donor2.CNhs12726.11574-120E8 | 17.3 | 0.429 |
| primary_cell | Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 16.8 | 0.438 |
| primary_cell | Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 16.0 | 0.416 |
| primary_cell | CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 14.5 | 0.385 |
| timecourse | Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 95.6 | 0.834 |
| timecourse | Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 94.9 | 0.902 |
| timecourse | Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 67.3 | 0.874 |
| timecourse | Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 52.3 | 0.847 |
| timecourse | mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 48.1 | 0.82 |
| timecourse | Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 47.8 | 0.793 |
| timecourse | Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 41.9 | 0.768 |
| timecourse | mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 41.1 | 0.782 |
| timecourse | Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 39.0 | 0.785 |
| timecourse | Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 36.6 | 0.745 |
| timecourse | Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 35.8 | 0.735 |
| timecourse | Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 35.4 | 0.743 |
| timecourse | MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 34.3 | 0.668 |
| timecourse | Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 34.3 | 0.757 |
| timecourse | Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 31.7 | 0.748 |
| timecourse | Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 30.7 | 0.736 |
| timecourse | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 27.6 | 0.538 |
| timecourse | Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 26.1 | 0.662 |
| timecourse | MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 26.1 | 0.587 |
| timecourse | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 24.5 | 0.519 |
| timecourse | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 24.0 | 0.492 |
| timecourse | H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 23.4 | 0.501 |
| timecourse | H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 23.2 | 0.505 |
| timecourse | H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 21.9 | 0.496 |
| timecourse | H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 21.8 | 0.507 |
| timecourse | iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 19.6 | 0.489 |
| timecourse | H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 19.4 | 0.475 |
| timecourse | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 16.4 | 0.414 |
| timecourse | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 16.2 | 0.41 |
| tissue | spleen, adult, pool1.CNhs10631.10025-101D7 | 115.3 | 0.907 |
| tissue | placenta, adult, pool1.CNhs10627.10021-101D3 | 111.7 | 0.904 |
| tissue | lymph node, adult, donor1.CNhs11788.10077-102A5 | 111.1 | 0.9 |
| tissue | esophagus, adult, pool1.CNhs10620.10015-101C6 | 107.4 | 0.907 |
| tissue | blood, adult, pool1.CNhs11761.10053-101G8 | 105.4 | 0.863 |
| tissue | appendix, adult.CNhs12842.10189-103D9 | 98.4 | 0.872 |
| tissue | tonsil, adult, pool1.CNhs10654.10047-101G2 | 97.5 | 0.878 |
| tissue | adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 96.4 | 0.906 |
| tissue | parotid gland, adult.CNhs12849.10199-103F1 | 95.4 | 0.915 |
| tissue | vagina, adult.CNhs12854.10204-103F6 | 91.9 | 0.898 |
| tissue | trachea, adult, pool1.CNhs10635.10029-101E2 | 91.7 | 0.901 |
| tissue | lung, adult, pool1.CNhs10625.10019-101D1 | 91.4 | 0.883 |
| tissue | thyroid, adult, pool1.CNhs10634.10028-101E1 | 90.2 | 0.903 |
| tissue | salivary gland, adult, pool1.CNhs11677.10093-102C3 | 88.6 | 0.909 |
| tissue | dura mater, adult, donor1.CNhs10648.10041-101F5 | 83.6 | 0.867 |
| tissue | tongue, adult.CNhs12853.10203-103F5 | 83.2 | 0.872 |
| tissue | small intestine, adult, pool1.CNhs10630.10024-101D6 | 82.8 | 0.901 |
| tissue | breast, adult, donor1.CNhs11792.10080-102A8 | 81.9 | 0.863 |
| tissue | thymus, adult, pool1.CNhs10633.10027-101D9 | 81.6 | 0.791 |
| tissue | Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 80.4 | 0.886 |
| tissue | SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 78.1 | 0.881 |
| tissue | heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 76.8 | 0.856 |
| tissue | colon, adult, pool1.CNhs10619.10014-101C5 | 73.2 | 0.87 |
| tissue | submaxillary gland, adult.CNhs12852.10202-103F4 | 72.5 | 0.892 |
| tissue | bladder, adult, pool1.CNhs10616.10011-101C2 | 71.3 | 0.844 |
| tissue | vein, adult.CNhs12844.10191-103E2 | 71.0 | 0.837 |
| tissue | kidney, adult, pool1.CNhs10622.10017-101C8 | 71.0 | 0.885 |
| tissue | thymus, fetal, pool1.CNhs10650.10043-101F7 | 69.4 | 0.735 |
| tissue | lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 69.2 | 0.847 |
| tissue | ductus deferens, adult.CNhs12846.10196-103E7 | 68.3 | 0.84 |
| tissue | heart, adult, pool1.CNhs10621.10016-101C7 | 67.8 | 0.841 |
| tissue | gall bladder, adult.CNhs12848.10198-103E9 | 64.5 | 0.846 |
| tissue | left atrium, adult, donor1.CNhs11790.10079-102A7 | 63.6 | 0.837 |
| tissue | prostate, adult, pool1.CNhs10628.10022-101D4 | 62.2 | 0.841 |
| tissue | heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 61.9 | 0.818 |
| tissue | liver, adult, pool1.CNhs10624.10018-101C9 | 61.4 | 0.877 |
| tissue | cervix, adult, pool1.CNhs10618.10013-101C4 | 60.6 | 0.789 |
| tissue | colon, fetal, donor1.CNhs11780.10070-101I7 | 60.5 | 0.793 |
| tissue | thyroid, fetal, donor1.CNhs11769.10060-101H6 | 58.4 | 0.799 |
| tissue | throat, adult.CNhs12858.10209-103G2 | 57.1 | 0.815 |
| tissue | aorta, adult, pool1.CNhs11760.10052-101G7 | 55.6 | 0.787 |
| tissue | seminal vesicle, adult.CNhs12851.10201-103F3 | 55.5 | 0.772 |
| tissue | stomach, fetal, donor1.CNhs11771.10062-101H8 | 54.8 | 0.789 |
| tissue | testis, adult, pool1.CNhs10632.10026-101D8 | 54.7 | 0.752 |
| tissue | pancreas, adult, donor1.CNhs11756.10049-101G4 | 53.1 | 0.838 |
| tissue | heart - mitral valve, adult.CNhs12855.10205-103F7 | 51.1 | 0.776 |
| tissue | spleen, fetal, pool1.CNhs10651.10044-101F8 | 50.5 | 0.735 |
| tissue | tongue, fetal, donor1.CNhs11768.10059-101H5 | 50.3 | 0.792 |
| tissue | smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 50.0 | 0.757 |
| tissue | uterus, fetal, donor1.CNhs11763.10055-101H1 | 49.2 | 0.736 |
| tissue | testis, adult, pool2.CNhs12998.10096-102C6 | 48.8 | 0.684 |
| tissue | ovary, adult, pool1.CNhs10626.10020-101D2 | 48.2 | 0.748 |
| tissue | spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 47.5 | 0.73 |
| tissue | epididymis, adult.CNhs12847.10197-103E8 | 46.1 | 0.752 |
| tissue | throat, fetal, donor1.CNhs11770.10061-101H7 | 45.9 | 0.718 |
| tissue | colon, adult, donor1.CNhs11794.10082-102B1 | 45.8 | 0.751 |
| tissue | uterus, adult, pool1.CNhs11676.10100-102D1 | 45.7 | 0.706 |
| tissue | penis, adult.CNhs12850.10200-103F2 | 45.7 | 0.747 |
| tissue | trachea, fetal, donor1.CNhs11766.10058-101H4 | 45.6 | 0.748 |
| tissue | umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 44.6 | 0.754 |
| tissue | retina, adult, pool1.CNhs10636.10030-101E3 | 43.5 | 0.726 |
| tissue | kidney, fetal, pool1.CNhs10652.10045-101F9 | 41.9 | 0.695 |
| tissue | temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 41.8 | 0.703 |
| tissue | skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 41.8 | 0.736 |
| tissue | pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 41.4 | 0.663 |
| tissue | lung, fetal, donor1.CNhs11680.10068-101I5 | 41.3 | 0.645 |
| tissue | left ventricle, adult, donor1.CNhs11789.10078-102A6 | 41.0 | 0.76 |
| tissue | rectum, fetal, donor1.CNhs11777.10067-101I4 | 40.2 | 0.638 |
| tissue | Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 39.7 | 0.702 |
| tissue | duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 38.7 | 0.701 |
| tissue | optic nerve, donor1.CNhs13449.10277-104E7 | 38.5 | 0.666 |
| tissue | cerebral meninges, adult.CNhs12840.10188-103D8 | 37.5 | 0.703 |
| tissue | heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 36.9 | 0.718 |
| tissue | cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 36.9 | 0.542 |
| tissue | medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 36.2 | 0.648 |
| tissue | small intestine, fetal, donor1.CNhs11773.10064-101I1 | 35.6 | 0.712 |
| tissue | caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 35.5 | 0.628 |
| tissue | globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 34.5 | 0.619 |
| tissue | skin, fetal, donor1.CNhs11774.10065-101I2 | 33.5 | 0.623 |
| tissue | thalamus, adult, donor10252.CNhs12314.10154-103A1 | 33.4 | 0.602 |
| tissue | pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 33.4 | 0.655 |
| tissue | pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 33.0 | 0.577 |
| tissue | medial frontal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 32.7 | 0.59 |
| tissue | eye, fetal, donor1.CNhs11762.10054-101G9 | 32.3 | 0.655 |
| tissue | locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 32.1 | 0.638 |
| tissue | heart, fetal, pool1.CNhs10653.10046-101G1 | 32.0 | 0.58 |
| tissue | substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 32.0 | 0.619 |
| tissue | occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 31.8 | 0.551 |
| tissue | hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 31.7 | 0.582 |
| tissue | pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 31.6 | 0.602 |
| tissue | diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 31.3 | 0.632 |
| tissue | cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 30.5 | 0.545 |
| tissue | medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 30.5 | 0.644 |
| tissue | parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 30.2 | 0.556 |
| tissue | medial temporal gyrus, adult, donor10252.CNhs12316.10156-103A3 | 29.3 | 0.54 |
| tissue | liver, fetal, pool1.CNhs11798.10086-102B5 | 29.2 | 0.668 |
| tissue | paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 28.8 | 0.611 |
| tissue | putamen, adult, donor10196.CNhs12324.10176-103C5 | 28.0 | 0.573 |
| tissue | pons, adult, pool1.CNhs10640.10033-101E6 | 27.5 | 0.604 |
| tissue | brain, adult, pool1.CNhs10617.10012-101C3 | 27.1 | 0.596 |
| tissue | frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 26.3 | 0.558 |
| tissue | amygdala, adult, donor10252.CNhs12311.10151-102I7 | 26.0 | 0.524 |
| tissue | nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 25.6 | 0.557 |
| tissue | spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 25.4 | 0.553 |
| tissue | corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 25.3 | 0.539 |
| tissue | occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 24.6 | 0.568 |
| tissue | diencephalon, adult.CNhs12610.10193-103E4 | 24.6 | 0.596 |
| tissue | insula, adult, pool1.CNhs10646.10039-101F3 | 24.1 | 0.535 |
| tissue | caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 23.9 | 0.512 |
| tissue | heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 23.2 | 0.622 |
| tissue | medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 22.9 | 0.55 |
| tissue | parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 22.3 | 0.53 |
| tissue | postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 22.2 | 0.539 |
| tissue | locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 21.6 | 0.513 |
| tissue | parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 21.1 | 0.505 |
| tissue | olfactory region, adult.CNhs12611.10195-103E6 | 20.3 | 0.467 |
| tissue | medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 19.6 | 0.471 |
| tissue | cerebellum, adult, pool1.CNhs11795.10083-102B2 | 19.5 | 0.42 |
| tissue | occipital pole, adult, pool1.CNhs10643.10036-101E9 | 19.3 | 0.477 |
| tissue | brain, adult, donor1.CNhs11796.10084-102B3 | 18.4 | 0.467 |
| tissue | hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 18.3 | 0.461 |
| tissue | thalamus - adult, donor10196.CNhs13794.10168-103B6 | 18.2 | 0.466 |
| tissue | temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 18.1 | 0.461 |
| tissue | parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 18.1 | 0.364 |
| tissue | temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 17.9 | 0.361 |
| tissue | spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 17.3 | 0.432 |
| tissue | occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 17.0 | 0.413 |
| tissue | medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 16.8 | 0.442 |
| tissue | duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 16.2 | 0.351 |
| tissue | globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 14.4 | 0.396 |
| tissue | amygdala - adult, donor10196.CNhs13793.10167-103B5 | 12.9 | 0.364 |
| tissue | occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 12.9 | 0.292 |
| tissue | skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 12.3 | 0.415 |
| tissue | skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 10.4 | 0.312 |
| tissue | brain, fetal, pool1.CNhs11797.10085-102B4 | 10.0 | 0.283 |